| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_421962d03d5c04a53901326e553b91bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_899455c63659aaec96424f7919e524c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2202-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D2315-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0281 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-44 |
| filingDate |
2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0da15a70354c6d4dfc708048ed126f |
| publicationDate |
2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8877060-B2 |
| titleOfInvention |
Methods for removing pathogens from a platelet preparation |
| abstract |
The present application relates to a method for removing pathogens from a transfusion grade platelet composition. The method comprises the steps of passing a platelet preparation through a first tangential flow filtration (TFF) device having a TFF filter, and collecting a retentate from the TFF device, wherein the retentate comprises filtered platelets to be used for transfusion. The platelet preparation comprises a platelet activation inhibitor and an anti-coagulant. During the TFF process, a diafiltration solution is added to the retentate to maintain the volume of the platelets. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11767511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529587-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000742-B2 |
| priorityDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |